Navigation Links
Shire Submits Biologics License Application (BLA) for REPLAGAL(R) With the U.S. Food and Drug Administration (FDA)
Date:12/22/2009

pproximately 20 years in men and 15 years in women, compared with the general population.[1,2] The principal causes of death are renal failure, cardiomyopathy and cerebrovascular events (e.g. stroke).[3]

Fabry disease affects an estimated 8,000 to 10,000 people worldwide.

About Gaucher disease

Gaucher disease is an autosomal recessive disorder caused by mutations in the GBA gene which results in a deficiency of the lysosomal enzyme beta-glucocerebrosidase. This enzymatic deficiency causes an accumulation of glucocerebroside, primarily in macrophages. In this lysosomal storage disorder (LSD), clinical features are reflective of the distribution of Gaucher cells in the liver, spleen, bone marrow, skeleton, and lungs. The accumulation of glucocerebrosidase in the liver and spleen leads to organomegaly. Bone involvement results in skeletal abnormalities and deformities as well as bone pain crises. Deposits in the bone marrow and splenic sequestration lead to clinically significant anemia and thrombocytopenia.

Gaucher disease is the most prevalent LSD. Gaucher disease has classically been categorized into 3 clinical types. Type 1 is the most common; it is distinguished from Type 2 and Type 3 by the lack of early neurological symptoms. Type 1 Gaucher disease is characterized by variability in signs, symptoms, severity, and progression.

Shire's velaglucerase alfa program included the largest and most comprehensive set of Phase III clinical trials conducted to date for Gaucher disease. Over 100 patients at 24 sites in 10 countries around the world have participated in the clinical studies.

Velaglucerase alfa is made using Shire's proprietary technology, in a human cell line. The enzyme produced has the exact human amino acid sequence and has a human glycosylation pattern.

    References

    1. MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical
       
'/>"/>
SOURCE Shire Plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Shire Expands its Award-Winning ADHD Support Resource, ADHDSupport.com, by Launching an ADHD Twitter(TM) Page
2. Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic
3. Shire Announces Publication of Open-Label Study on Coadministration of INTUNIV(TM) (guanfacine) Extended-Release Tablets with Stimulants
4. Shire Re-Launches FOCUS, an Online, Personalized Patient Support Program for Adults with ADHD Taking Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII
5. Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD
6. Shire Continues to Deliver Excellent Growth From Core Products
7. Shire to Present Important Study Findings on its ADHD Treatments at a Major Psychiatric Meeting on October 29 and 30
8. Shire Presents Results of Five Lialda(R) (mesalamine) Analyses at ACG 2009 Annual Scientific Meeting
9. Shire Targets Fourth Quarter Filing of BLA for REPLAGAL(R) for Fabry Disease With U.S. FDA
10. Shire and Sandoz Settle all Pending Litigation Concerning ADDERALL XR(R)
11. Veriscrip and DAMMAD Team Up to Combat Prescription Drug Abuse in New Hampshire
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... , Sept. 22, 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: ... and fiscal 2014 ended July 31, 2014 on Monday, September ... to discuss the results at 11:00 AM ET. Participating in ... Andrew A. Krakauer , President and CEO; Jorgen ... A. Sheldon , Senior Vice President, CFO and Treasurer; and ...
(Date:9/22/2014)... , Sept. 22, 2014  Inovio Pharmaceuticals, Inc. ... has initiated a phase I clinical trial in ... the safety, tolerability, and immunogenicity of INO-3106. This ... causes most aerodigestive cancers. Aerodigestive cancers ... cords, and parts of the esophagus and windpipe. ...
(Date:9/22/2014)... , Sept. 22, 2014  Seres Health, a clinical-stage ... the human microbiome, today announced that it has been ... Fierce 15 biotechnology companies, designating it as one of ... "Amid a great deal of ain,t-it-cool ... focus and commitment to practical therapeutic development," says ...
Breaking Medicine Technology:Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Fourth Quarter And Fiscal 2014 Ended July 31, 2014 2Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 2Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 3Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 4Seres Health Named a "Fierce 15" Biotech Company for 2014 2
... Jan. 4, 2012 /PRNewswire/ -- CryoLife, Inc. (NYSE: ... company focused on cardiac and vascular surgery, announced today ... the position of Vice President, Research and Development; and ... Vice President, Market Development Surgical Adhesives and Starch Medical ...
... /PRNewswire-Asia/ -- The 2011 Medical Korea Awards ceremony was ... the awards ceremony, 10 outstanding medical tourism service providers ... medical tourism agencies, designated as ,first movers, in the ... Yonsei Severance Hospital (General Director: Park Yong-won) won this ...
Cached Medicine Technology:CryoLife Enhances Management Team with Promotions 2CryoLife Enhances Management Team with Promotions 3CryoLife Enhances Management Team with Promotions 4CryoLife Enhances Management Team with Promotions 5Medical Korea Offers 2011 Awards to Top Medical Tourism Service Providers (Institutions) 2
(Date:9/22/2014)... Oaks, CA (PRWEB) September 22, 2014 ... now offering a special offer for Invisalign. Invisalign is ... smiles and correct bite problems. Typical pricing can vary ... and the number of aligners that are needed. During ... for just $4,495. , About a fifth of the ...
(Date:9/22/2014)... The invitation only Summit held on ... industry executives and thought leaders from major fitness ... Fitness, and Xsport Fitness. Also in attendance were ... agencies and private equity investors representing over 1,500 ... The Summit highlighted best practices for solving new ...
(Date:9/22/2014)... -- New research raises doubts about the possible benefits ... cancer who used e-cigarettes along with traditional cigarettes were ... the devices, a Memorial Sloan Kettering study found. These ... likely -- to have quit smoking than patients who ... Sept. 22 in Cancer , involved almost 1,100 ...
(Date:9/22/2014)... 2014 At the 10th Clinton ... Nutrition Partnership (SNP) announced the successful launch of ... Cardiovascular Risk Reduction Program for Women. The announcement ... mitigate their risk of heart disease through a ... plan for addressing significant global challenges made by ...
(Date:9/22/2014)... NY (PRWEB) September 22, 2014 Tristar ... American icon Jack LaLanne, best known as the 'Godfather ... "ANYTHING IS POSSIBLE" premiering September 24th at the ... documentary gives an inspiring insight behind the man whose ... benefits of fitness and nutrition. The name of the ...
Breaking Medicine News(10 mins):Health News:Thousand Oaks Cosmetic Dentist, Sharon Shamoiel DDS, Is Now Offering a Special on Invisalign 2Health News:Motionsoft Concludes Inaugural 2014 Technology Summit 2Health News:Motionsoft Concludes Inaugural 2014 Technology Summit 3Health News:E-Cigarettes Don't Help Cancer Patients Quit Smoking: Study 2Health News:At 2014 Clinton Global Initiative Annual Meeting, Seafood Nutrition Partnership Announces Pilot Program to Reduce Women’s Heart Disease Risks 2Health News:At 2014 Clinton Global Initiative Annual Meeting, Seafood Nutrition Partnership Announces Pilot Program to Reduce Women’s Heart Disease Risks 3Health News:At 2014 Clinton Global Initiative Annual Meeting, Seafood Nutrition Partnership Announces Pilot Program to Reduce Women’s Heart Disease Risks 4Health News:Tristar Products Premieres The Jack LaLanne Documentary at TriBeCa Film Center in New York City 2Health News:Tristar Products Premieres The Jack LaLanne Documentary at TriBeCa Film Center in New York City 3
... to directly measure the brain,s temperature without inserting a probe ... get the brain,s precise temperature with a device the diameter ... to findings presented May 1 at the annual meeting of ... first time that anyone has presented data on the brain ...
... Johns Hopkins have shown in laboratory experiments in mice ... inside the heart,s muscle cells blunts the most serious ... These include heart muscle enlargement, scar tissue formation ... Specifically, the Johns Hopkins team found that their intervention ...
... -- Children born to women exposed to bisphenol A (BPA) ... to experience wheezing early in life, according to a new ... many hard plastic food containers, water bottles and the lining ... in more than 90 percent of the U.S. population, the ...
... News) -- A new study finds that different patterns of ... arterial stiffness, which is associated with cardiovascular disease. Stiff ... and are also associated with a buildup of plaque in ... to a heart attack. In this study, Dr. Danny ...
... reserve" in early-onset Alzheimer,s disease (AD) and PET-CT examinations ... patients. "Although early-onset Alzheimer,s dementia is quite ... carry the diagnosis," said Dr. Jacob Richard Hodge, lead ... Rochester, Minn. "Symptoms are often unexpected and support networks ...
... have discovered a link between low levels of vitamin D ... May 1 at the annual meeting of the Pediatric Academic ... play an important role in anemia. Anemia, which occurs ... is diagnosed and tracked by measuring hemoglobin levels. Symptoms of ...
Cached Medicine News:Health News:Researchers develop device to measures brain temperature non-invasively 2Health News:Animal studies reveal new route to treating heart disease 2Health News:Animal studies reveal new route to treating heart disease 3Health News:Mom's Exposure to Plastics Chemical Tied to Baby's Wheeze 2Health News:PET-CT exams help identify cognitive reserve in early-onset Alzheimer's disease 2Health News:Low vitamin D in kids may play a role in anemia 2
A simple solution to hand assisted laparoscopic surgery....
GelPort hand access laparoscopy combines the patient outcomes of minimally invasive surgery with the speed and precision of open surgery....
... HandPort Systems non-adhesive sealing method ... Laparoscopic Surgrery (HALS) procedures, allowing ... and palpate throughout. Because HALS ... 6 cm, patients experience less ...
The CPAP TREND 110 delivers performance with quiet operation. Can be used together with the SomnoPlus CPAP Mask and AquaTrend Heated Humidifier....
Medicine Products: